Bisacodyl
- Generic Name
- Bisacodyl
- Brand Names
- Alophen Reformulated Jan 2008, Bi-peglyte, Bisac-evac, Carters Little Pills, Dulcolax, Fleet Mineral Oil, Gavilyte-H and Bisacodyl
- Drug Type
- Small Molecule
- Chemical Formula
- C22H19NO4
- CAS Number
- 603-50-9
- Unique Ingredient Identifier
- 10X0709Y6I
- Background
Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).
Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.
- Indication
Bisacodyl is indicated to relieve occasional constipation and irregularity.
- Associated Conditions
- Bowel movement irregularity, Constipation, Occasional Constipation
- Associated Therapies
- Bowel preparation therapy
Sanofi Completes €10 Billion Sale of Opella to CD&R, Transforms into Pure-Play Biopharma
• Sanofi has finalized the sale of a 50% controlling stake in its consumer healthcare business Opella to CD&R, receiving approximately €10 billion in net cash proceeds.
• Opella emerges as the third-largest global player in the OTC and VMS market, with iconic brands like Allegra, Doliprane, and Dulcolax serving over 500 million consumers across 100 countries.
• The transaction marks Sanofi's strategic pivot to become a pure-play biopharma company focused on breakthrough medicines and vaccines, while maintaining a 48.2% stake in Opella.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath